Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

por Connick, Peter, Kolappan, Madhan, Crawley, Charles, Webber, Daniel J, Patani, Rickie, Michell, Andrew W, Du, Ming-Qing, Luan, Shi-Lu, Altmann, Daniel R, Thompson, Alan J, Compston, Alastair, Scott, Michael A, Miller, David H, Chandran, Siddharthan
Publicado 2012

The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessmen...

por Connick, Peter, Kolappan, Madhan, Patani, Rickie, Scott, Michael A, Crawley, Charles, He, Xiao-Ling, Richardson, Karen, Barber, Kelly, Webber, Daniel J, Wheeler-Kingshott, Claudia AM, Tozer, Daniel J, Samson, Rebecca S, Thomas, David L, Du, Ming-Qing, Luan, Shi L, Michell, Andrew W, Altmann, Daniel R, Thompson, Alan J, Miller, David H, Compston, Alastair, Chandran, Siddharthan
Publicado 2011